Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

Archive ouverte

Donzé, C. | Papeix, C. | Lebrun-Frenay, C. | Collongues, N. | de Seze, M. | Dinh, A. | Even, A. | Scheiber-Nogueira, C. | Bensa, C. | Bourre, B. | Carra-Dallière, C. | Ciron, J. | Cohen, M. | Guennoc, A.M. | Louapre, C. | Lebreton, F. | Michel, L. | Maillart, E. | Audoin, B. | Ayrignac, X. | Bernady, P. | Brochet, B. | Clavelou, P. | Colamarino, R. | Declemy, A. | de Seze, J. | Derache, N. | Faucheux, J.-M. | Heinzlef, O. | Labauge, P. | Laplaud, D. | Lepage, E. | Leray, E. | Magy, L. | Mathey, G. | Mekies, C. | Mondain, V. | Planque, E. | Pelletier, J. | Pittion, S. | Stankhof, B. | Tournaire, P. | Thouvenot, Eric | Vukusic, S. | Wiertlevski, S. | Zephir, H. | Alchaar, H. | Androdias, G. | Benazet, M. | Bensmail, D. | Biotti, D. | Blanchard-Dauphin, A. | Bonnan, M. | Boutière, C. | Branger, P. | Bresch, S. | Bru, J.-P. | Camdessanché, J.-P. | Castel Canal, E. | Coustans, M. | Casez, O. | Castan, B. | Creange, A. | Creisson, E. | de Broucker, T. | Depaz, R. | Douay, X. | Dulau, C. | Durand-Dubief, F. | Fagniez, O. | Faucher, M. | Floch, A. | Fournier, M. | Fromont, A. | Gallien, P. | Gamé, X. | Gault, D. | Gayou, A. | Giroux, M. | Gout, O. | Grimaud, J. | Hautecoeur, P. | Kerbrat, Anne | Kremer, L. | Kwiatkowski, A. | Labeyrie, C. | Lachaud, S. | Lanctin-Garcia, C. | Lanotte, L. | Manchon, E. | Maurousset, A. | Milor, A.-M. | Moisset, X. | Mont-Cuquet, A. | Moreau, T. | Ouallet, J.-C. | Patry, I. | Peaureaux, D. | Pouget, M.-C. | Pourcher Martinez, V. | Radot, C. | Ruet, A. | Saint-Val, C. | Salmon, A. | Taithe, F. | Tatevin, P. | Vaillant, M. | Stahl, J.-P. | Vuoto, F. | Zaenker, C.

Edité par CCSD ; Elsevier Masson -

International audience. Objectives: Establish recommendations for the management of UTIs in MS patients.Background: Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of the most common comorbidities potentially responsible for deaths from urinary sepsis.Methods: The recommendations attempt to answer three main questions about UTIs and MS. The French Group for Recommendations in MS (France4MS) did a systematic review of articles from PubMed and universities databases (01/1980-12/2019). The RAND/UCLA appropriateness method, which has been developed to synthesize the scientific literature and expert opinions on health care topics, was used for reaching a formal agreement. 26 MS experts worked on the full-text review and a group of 70 multidisciplinary health care specialists validated the final evaluation of summarized evidences.Results: UTIs are not associated with an increased risk of relapse and permanent worsening of disability. Only febrile UTIs worsen transient disability through the Uhthoff phenomenon. Some immunosuppressive treatments increase the risk of UTIs in MS patients and require special attention especially in case of hypogammaglobulinemia. Experts recommend to treat UTIs in patients with MS, according to recommendations of the general population. Prevention of recurrent UTIs requires stabilization of the neurogenic bladder. In some cases, weekly oral cycling antibiotics can be proposed after specialist advice. Asymptomatic bacteriuria should not be screened for or treated systematically except in special cases (pregnancy and invasive urological procedures).Conclusion: Physicians and patients should be aware of the updated recommendations for UTis and MS.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion